Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors

NCT02457793

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +27 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma

NCT00788775

Conditions
Acral Melanoma, Melanoma, Mucosal Lentiginous Melanoma, +11 more
Locations
  • The Angeles Clinic and Research Institute Santa Monica, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

NCT02267967

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • the 307 Hospital of People's Liberation Army Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Completed

Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas

NCT02454634

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • Charité Berlin, Neurosurgery Berlin, Germany
  • University Hospital Dresden, Neurosurgery Dresden, Germany
  • University Hospital Essen, Internal Medicine Essen, Germany
  • University Hospital Frankfurt, Neurooncology Frankfurt am Main, Germany
View Trial Details

Related conditions